RAYMOND JAMES & ASSOCIATES - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$294,000
-9.8%
3,455
-62.4%
0.00%
Q2 2020$326,000
+102.5%
9,186
-24.5%
0.00%
Q3 2019$161,000
-9.6%
12,171
-5.4%
0.00%
Q2 2019$178,000
-36.9%
12,861
-12.5%
0.00%
Q1 2019$282,000
+442.3%
14,695
-29.2%
0.00%
Q1 2016$52,00020,7500.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders